Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
$419M |
| 2 |
Exxon Mobil
XOM
|
$203M |
| 3 |
Visa
V
|
$192M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$188M |
| 5 |
Microsoft
MSFT
|
$187M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
$58.6M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$43M |
| 3 |
BCE
BCE
|
$36.9M |
| 4 |
PETM
PETSMART INC
PETM
|
$11.8M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
$11.2M |
Sector Composition
| 1 | Healthcare | 15.69% |
| 2 | Technology | 14.65% |
| 3 | Industrials | 10.83% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Consumer Staples | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$140B
| $227M | 0.61% | 2,311,524 +906,000 | +64% | +$88.9M |
|
27
Amazon
AMZN
$2.44T
| $223M | 0.6% | 599,541 +234,400 | +64% | +$87.2M |
|
28
Cisco
CSCO
$274B
| $214M | 0.57% | 7,789,893 +3,027,100 | +64% | +$83.3M |
|
29
UnitedHealth
UNH
$281B
| $214M | 0.57% | 1,810,027 +519,700 | +40% | +$61.5M |
|
30
Canadian National Railway
CNI
$60.4B
| $208M | 0.56% | 3,125,100 +585,900 | +23% | +$39.1M |
|
31
Bristol-Myers Squibb
BMY
$96B
| $194M | 0.52% | 3,009,452 +938,000 | +45% | +$60.5M |
|
32
CVS Health
CVS
$92.8B
| $191M | 0.51% | 1,850,010 +658,200 | +55% | +$67.9M |
|
33
Amgen
AMGN
$155B
| $186M | 0.5% | 1,165,608 +459,300 | +65% | +$73.4M |
|
34
Comcast
CMCSA
$125B
| $185M | 0.49% | 3,275,784 +1,277,300 | +64% | +$72.1M |
|
35
Altria Group
MO
$113B
| $180M | 0.48% | 3,597,294 +1,106,600 | +44% | +$55.4M |
|
36
Philip Morris
PM
$260B
| $178M | 0.48% | 2,366,531 +914,900 | +63% | +$68.9M |
|
|
AGN
37
DELISTED
Allergan plc
AGN
| $176M | 0.47% | 592,536 +330,098 | +126% | +$98.2M |
|
38
Medtronic
MDT
$119B
| $176M | 0.47% | 2,260,263 +1,265,229 | +127% | +$98.7M |
|
39
Union Pacific
UNP
$133B
| $172M | 0.46% | 1,590,272 +494,300 | +45% | +$53.5M |
|
40
Automatic Data Processing
ADP
$123B
| $167M | 0.44% | 1,944,485 +171,500 | +10% | +$14.7M |
|
41
Schlumberger
SLB
$55B
| $164M | 0.44% | 1,960,275 +744,400 | +61% | +$62.1M |
|
42
Boeing
BA
$177B
| $163M | 0.44% | 1,085,691 +425,100 | +64% | +$63.8M |
|
43
Suncor Energy
SU
$50.1B
| $160M | 0.43% | 5,511,264 +989,400 | +22% | +$28.8M |
|
44
Enbridge
ENB
$105B
| $155M | 0.41% | 3,223,000 +613,600 | +24% | +$29.4M |
|
45
RTX Corp
RTX
$212B
| $155M | 0.41% | 1,319,321 +511,300 | +63% | +$59.9M |
|
46
General Mills
GIS
$26.4B
| $154M | 0.41% | 2,727,516 +142,100 | +5% | +$8.04M |
|
47
3M
MMM
$82.8B
| $153M | 0.41% | 927,404 +355,100 | +62% | +$58.6M |
|
48
Abbott
ABT
$231B
| $153M | 0.41% | 3,301,318 +797,700 | +32% | +$37M |
|
49
Biogen
BIIB
$19.4B
| $152M | 0.41% | 359,799 +140,500 | +64% | +$59.3M |
|
50
Eli Lilly
LLY
$657B
| $148M | 0.39% | 2,030,643 +541,400 | +36% | +$39.3M |
|